Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL18889504 | 0.93 | LMNA (0.53) | LMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL29932170 | 0.93 | LMNA (0.53) | LMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL29572984 | 0.93 | LMNA (0.53) | LMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL40229 | 0.93 | — | — | |
| Acrylic Acid SCHEMBL5884991 | 0.93 | LMNA (0.53) | LMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL566319 | 0.91 | LMNA (0.50) | LMNAALDH1A1ALOX15HSD17B10 | |
| Benzene SCHEMBL9277815 | 0.88 | LMNA (0.48) | LMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL8754533 | 0.86 | LMNA (0.46) | LMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL9566734 | 0.86 | LMNA (0.46) | LMNAALDH1A1ALOX15HSD17B10 | |
| Acrylic Acid Methyl Ester SCHEMBL27600548 | 0.80 | HCAR2 (0.39) | ALDH1A1HSD17B10HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117202878-A | Adhesive article and method of making the same | 金德瓦药物控释有限公司 | 2023-12-08 | — | — | CN | disclosed |
| US-20230165723-A1 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | KINDEVA DRUG DELIVERY L.P. (US) | 2023-06-01 | — | — | US | disclosed |
| EP-4142668-A1 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | Kindeva Drug Delivery L.P. (US) | 2023-03-08 | — | — | EP | disclosed |
| US-20220008352-A1 | Composition for the Transdermal Delivery of Fentanyl | KINDEVA DRUG DELIVERY L.P. (US) | 2022-01-13 | — | — | US | disclosed |
| WO-2021222215-A1 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | KINDEVA DRUG DELIVERY L.P. (US) | 2021-11-04 | — | — | WO | disclosed |
| US-20200253887-A1 | Composition for the Transdermal Delivery of Fentanyl | MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT | 2020-08-13 | — | — | US | disclosed |
| US-20190167603-A1 | Composition for the Transdermal Delivery of Fentanyl | 3M INNOVATIVE PROPERTIES CO (US) | 2019-06-06 | — | — | US | disclosed |
| US-20180153823-A1 | Composition for the Transdermal Delivery of Fentanyl | 3M INNOVATIVE PROPERTIES CO (US) | 2018-06-07 | — | — | US | disclosed |
| US-20170296486-A1 | Composition for the Transdermal Delivery of Fentanyl | 3M INNOVATIVE PROPERTIES CO (US) | 2017-10-19 | — | — | US | disclosed |
| US-20170035704-A1 | Composition for the Transdermal Delivery of Fentanyl | 3M INNOVATIVE PROPERTIES CO (US) | 2017-02-09 | — | — | US | disclosed |
| WO-2001030316-A2 | TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1-AZABICYCLO(2.2.1)HEPTAN-3-ONE, 0-(3(3-METHOXYPHENYL)-2-PROPYNYL)OXIME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-05-03 | — | — | WO | disclosed |
| US-6132760-A | CONTAINS A THERAPEUTICALLY EFFECTIVE AMOUNT OF TESTOSTERONE AND A DELIVERY ENHANCING ADJUVANT COMPRISING A TERPENE. | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-10-17 | — | — | US | disclosed |
| US-6086911-A | FLEXIBLE BACKING OF NONWOVEN THERMOPLASTIC POLYMER WEB, MOLECULAR ORIENTED FIBERS WITH PATTERNS FOR DRUG DELIVERY | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-07-11 | — | — | US | disclosed |
| EP-0979072-A1 | TRANSDERMAL DEVICE FOR THE DELIVERY OF TESTOSTERONE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-02-16 | — | — | EP | disclosed |
| EP-0869781-A1 | TRANSDERMAL DEVICE FOR THE DELIVERY OF FLURBIPROFEN | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0868177-A1 | DRUG DELIVERY DEVICE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-10-07 | — | — | EP | disclosed |
| WO-1998037871-A1 | TRANSDERMAL DEVICE FOR THE DELIVERY OF TESTOSTERONE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-09-03 | — | — | WO | disclosed |
| US-5702720-A | INVOLVING AN ACRYLATE OR MATHACRYLATE BASED COPOLYMER, A SKIN PENETRATION ENHANCER, A POLYVINYLPYRROLIDONE POLYMER AND FLURBIPROFEN DRUG; ANTIINFLAMATORY, ANALGESIC AND ANTIPYRETIC AGENT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-12-30 | — | — | US | disclosed |
| WO-1997023206-A1 | DRUG DELIVERY DEVICE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-07-03 | — | — | WO | disclosed |
| WO-1997023205-A1 | TRANSDERMAL DEVICE FOR THE DELIVERY OF FLURBIPROFEN | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-07-03 | — | — | WO | disclosed |